---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-007827"
form_type: "8-K"
ticker: "ROIV"
cik: "0001635088"
company_name: "Roivant Sciences Ltd."
filed_at: "2023-02-21T23:59:59+00:00"
generated_at: "2026-06-19T07:02:11.784082+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Vivek Ramaswamy resigns from Roivant board to pursue outside opportunity

## Summary
- Vivek Ramaswamy, Class II director, resigned effective February 20, 2023.
- Resignation not due to any disagreement with the company, management, or board.
- He is leaving to imminently pursue an outside opportunity.
- No replacement director has been announced.

## SEC filing metadata
- accession: 0001140361-23-007827
- form_type: 8-K
- ticker: ROIV
- cik: 0001635088
- company_name: Roivant Sciences Ltd.
- filed_at: 2023-02-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1635088/000114036123007827/0001140361-23-007827-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1635088/000114036123007827/brhc10048536_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-007827
- JSON: https://secwatch.observer/filing/0001140361-23-007827.json
- Plain text: https://secwatch.observer/filing/0001140361-23-007827.txt

## Key facts
- Executive change
  Vivek Ramaswamy departed as Class II director at Roivant Sciences Ltd..
  - Action: stepped down
  - Role: Class II director
  source text: Vivek Ramaswamy, a Class II director of Roivant Sciences Ltd. (the “Company”), stepped down from his role on the Company’s board of directors (the “Board”) effective immediately, to imminently pursue an outside opportunity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1635088/000114036123007827/0001140361-23-007827-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.